Clinical Trials Directory

Trials / Completed

CompletedNCT06005376

Development of a Celiac Safe Food Additive

Development of a Celiac Safe Food Additive: An Intervention Study in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Chalmers University of Technology · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial was to investigate if intestinal deamidation of gliadin from wheat bread could be hindered by adding a E304i/zinc additive. The study was a randomized double-blind 4-week crossover intervention in 20 healthy volunteers in which the participants ingested 2 bread rolls a day during the intervention weeks. The question it aimed to answer was if there was a difference in blood levels of deamidated gliadin peptides after ingestion of the reference wheat bread compared with the wheat bread containing the food additive.

Conditions

Interventions

TypeNameDescription
OTHERBreakfast rolls consisting of wheat flour with and without a E304i/zinc additiveThe participants were provided with two Breakfast rolls (a 40 g) a day during the intervention week. In addition, they were provided with gluten-free foods during the whole trial.

Timeline

Start date
2020-07-29
Primary completion
2020-11-02
Completion
2020-11-02
First posted
2023-08-22
Last updated
2023-08-22

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06005376. Inclusion in this directory is not an endorsement.